AstraZeneca Gets CDCSO Panel Nod To Import, Market Eculizumab To Treat Paroxysmal Nocturnal Hemoglobinuria
Keeping in mind that there is an unmet medical need in India, the Topic Specialist Board (SEC) functional under the Central Drug Requirement Control Organisation (CDSCO) has provided approval to the medication significant AstraZeneca to import and market...